Breaking Finance News

Zurich Insurance Group (ADR) (OTC:ZURVY) has been upgraded from Neutral to Overweight in a statement by JP Morgan earlier today.

Having a price of $30.34, Zurich Insurance Group (ADR) (OTC:ZURVY) traded 1.07% higher on the day. With the last stock price up 4.93% from the two hundred day average, compared with the Standard & Poor's 500 Index which has increased 0.04% over the same period. ZURVY has recorded a 50-day average of $30.23 and a two hundred day average of $28.92. Trade Volume was down over the average, with 5,084 shares of ZURVY changing hands under the typical 73,535

JP Morgan has upgraded Zurich Insurance Group (ADR) (OTC:ZURVY) from Neutral to Overweight in a statement released on 9/12/2017.

Recent Performance Chart

Zurich Insurance Group (ADR) (OTC:ZURVY)

Zurich Insurance Group (ADR) has PE ratio of 14.75 with a one year low of $25.08 and a one year high of $30.89 and has a market capitalization of $0.

General Company Details For Zurich Insurance Group (ADR) (OTC:ZURVY)

Zurich Insurance Group AG is a holding company. The Company and its subsidiaries provide insurance products and related services. Its segments include General Insurance, Global Life, Farmers, Other Operating Businesses and Non-Core Businesses. The General Insurance segment provides a range of motor, home and commercial products and services for individuals, as well as small and large businesses. The Global Life segment is engaged in providing unit-linked, protection and corporate propositions through global distribution and proposition pillars. The Farmers segment, through Farmers Group, Inc. and its subsidiaries, provides certain non-claims administrative and management services to the Farmers Insurance Exchange, Fire Insurance Exchange, Truck Insurance Exchange, and their subsidiaries and affiliates. The Other Operating Businesses segment includes the Company's Holding and Financing activities. The Non-Core Businesses segment includes its insurance and reinsurance businesses.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *